Keyphrases
Next-generation Sequencing
100%
Neuropathology
100%
Central Nervous System Infections
100%
Infection Diagnosis
100%
Spinal Cord
37%
Infectious Agents
25%
Microbiome
25%
Microbiology
12%
In(III)
12%
Infectious Diseases
12%
Diagnostic Tool
12%
Clinical Outcomes
12%
Computational Analysis
12%
Pathogenic Process
12%
Novel Diagnostics
12%
Potential Gains
12%
Brain Tissue
12%
Infectious Pathogens
12%
Inconclusive Result
12%
Prospective pilot Study
12%
Method Validation
12%
Pathogenic Microorganisms
12%
Direct Sequencing
12%
Tissue Biopsy
12%
Sequence Reads
12%
Non-contributory
12%
Speed Sensitivity
12%
Neurologic Problems
12%
Analysis pipeline
12%
Metagenomic Study
12%
CNS Infection
12%
Direct RNA Sequencing
12%
Unbiased Sequencing
12%
Neuroinflammatory Disorders
12%
Meningeal Biopsy
12%
Medicine and Dentistry
Infection
100%
Nervous System
100%
Next Generation Sequencing
100%
Pathogen
37%
Spinal Cord Biopsy
37%
Microbiome
25%
Health Care Cost
12%
DNA Sequence
12%
RNA Sequence
12%
Brain Tissue
12%
Biopsy Technique
12%
Infectious Disease
12%
Central Nervous System Infection
12%
Disease
12%
Pathogenic Microbes
12%
Meningeal Biopsy
12%
Immunology and Microbiology
Next Generation Sequencing
100%
Neurological System
100%
Infection
100%
Infectious Agent
62%
Spinal Cord
37%
Microbiome
25%
RNA Sequence
12%
DNA Sequence
12%
Metagenomics
12%
Microbiology
12%
Brain Tissue
12%
Pathogenic Microbes
12%
Biochemistry, Genetics and Molecular Biology
Next Generation Sequencing
100%
Infectious Agent
62%
Microbiome
25%
DNA Sequence
12%
RNA Sequence
12%
Metagenomics
12%
Veterinary Science and Veterinary Medicine
Protocerebrum
100%
Infectious Disease
100%